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Nitric oxide orchestrates metabolic rewiring
in M1 macrophages by targeting aconitase 2
and pyruvate dehydrogenase
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Profound metabolic changes are characteristic of macrophages during classical activation and
have been implicated in this phenotype. Here we demonstrate that nitric oxide (NO) pro-
duced by murine macrophages is responsible for TCA cycle alterations and citrate accu-
mulation associated with polarization. 13C tracing and mitochondrial respiration experiments
map NO-mediated suppression of metabolism to mitochondrial aconitase (ACO2). More-
over, we ﬁnd that inﬂammatory macrophages reroute pyruvate away from pyruvate dehy-
drogenase (PDH) in an NO-dependent and hypoxia-inducible factor 1α (Hif1α)-independent
manner, thereby promoting glutamine-based anaplerosis. Ultimately, NO accumulation leads
to suppression and loss of mitochondrial electron transport chain (ETC) complexes. Our data
reveal that macrophages metabolic rewiring, in vitro and in vivo, is dependent on NO tar-
geting speciﬁc pathways, resulting in reduced production of inﬂammatory mediators. Our
ﬁndings require modiﬁcation to current models of macrophage biology and demonstrate that
reprogramming of metabolism should be considered a result rather than a mediator of
inﬂammatory polarization.
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Macrophages are important players in the regulation ofimmune responses and tissue homeostasis. Productionof proinﬂammatory mediators, microbicidal activity,
and release of reactive oxygen species (ROS) have been associated
with “classical” activation while “alternative” activation mediates
healing, humoral responses and tumor progression1. Generally,
classical “M1” macrophages utilize glycolysis, whereas “M2”,
differentiated in interleukin 4 (IL4), rely on oxidative phos-
phorylation (OXPHOS)2. Shifts toward Warburg metabolism
have been well characterized in lipopolysaccharide (LPS) or
LPS and interferon (IFN)γ-activated macrophages3,4. The
concomitant increases in glucose consumption and lactate pro-
duction, together with reduced OXPHOS have been termed
“commitment” to a glycolytic state, crucial for supporting many
aspects of macrophage polarization3,5,6. Nonetheless studies have
reported complex metabolic footprints in macrophages activated
under certain stimuli and tissue environments7,8. As a result, the
possibility of modulating metabolic pathways to skew immune
cells towards anti-tumoral phenotypes has driven interest in both
immunology and cancer biology.
Macrophage reprogramming is associated with accumulation
of key metabolites tied to macrophage functions2,9. The accu-
mulation of citrate, succinate and itaconate are considered result
of dysfunctional or “broken” citric acid cycle, also known as TCA
cycle, as deﬁned by reduction in carbon transition from citrate to
alpha-ketoglutarate (α-KG), a decline in isocitrate dehydrogenase
(IDH1) messenger RNA (mRNA) levels, and decreased succinate
dehydrogenase (SDH) activity10. Accumulated citrate supports
synthesis of lipids for production of inﬂammatory mediators11,12
while succinate has been implicated in the stabilization of HIF1α4,
which in turns promotes production of IL1β and inhibits pyr-
uvate dehydrogenase (PDH)13 limiting acetyl coenzyme A for
the TCA cycle. Itaconate, the product of decarboxylation of
cis-aconitate by IRG114,15, possesses antimicrobial activity16,
inhibits SDH, thereby promoting succinate accumulation and
regulating ROS production14,17,18 and acts as an immunomo-
dulatory metabolite19,20. Despite the many functions ascribed to
metabolite changes during polarization, the underlying mechan-
isms of reprogramming are still poorly deﬁned.
More than 30 years ago, NO-mediated inhibition of complex
I (CI), II, III, and IV of the mitochondrial ETC21–24 was
described as a mechanism by which activated macrophages kill
tumor cells21. In M1 macrophages NO is largely the product of
inducible nitric oxide synthase (iNOS or Nos2), which, unlike
neuronal NOS (nNOS or Nos3) or endothelial NOS (eNOS or
Nos1), strongly increases during stimulation with LPS25. We
previously demonstrated that NOS-derived NO is both neces-
sary and sufﬁcient for repression of OXPHOS during M1
polarization in bone marrow-derived macrophages (BMDMs).
Moreover, we found that IL10 tunes glycolytic commitment by
limiting the production of NO3. Given the ability of NO to
regulate mitochondrial respiration, we investigated the possi-
bility that this soluble gas might play a role in other aspects of
macrophage programming. We ﬁnd that, upon stimulation with
LPS or LPS/IFNγ, NO production dictates intracellular routes
of carbon utilization skewing mitochondrial metabolism at
aconitase 2 and potently suppressing carbon ﬂow into the TCA
via PDH in a HIF1α-independent manner. Our work reveals
that NO orchestrates the accumulation of several intermediates,
ultimately leading to suppression and loss of mitochondrial
ETC complexes. Moreover, we ﬁnd that cytokine production is
unaffected in macrophages that fail to rewire their mitochon-
dria demonstrating that loss of OXPHOS and broken TCA
cycle are results of inﬂammatory polarization rather than
mediators of the process.
Results
Nos2−/− macrophages show intact metabolism and inﬂam-
matory machinery. In order to assess what aspects of metabolic
programming other than suppression of OXPHOS might be
driven by NO we carried out detailed metabolic analysis. Steady-
state metabolomics contrasting WT and Nos2−/− BMDMs sti-
mulated with LPS for 24 h demonstrated profound differences.
Analysis of metabolites involved in arginine metabolism showed
that BMDMs accumulate citrulline as result of conversion of
arginine during the production of NO by NOS2 (Fig. 1a). Mac-
rophages lacking NOS2 had low citrulline and increased orni-
thine, consistent with alternative destination for arginine through
arginase, whereas putrescine levels increased to the same extent in
WT and Nos2−/− (Fig. 1a). Consistent with previous reports,
activated WT were glycolytic (Fig. 1b) and Nos2−/− macrophages
had higher levels of glycolytic intermediates, but showed rates of
glycolysis comparable to WT (Fig. 1b and Supplementary
Fig. 1A–D) with greater glycolytic reserve (Supplementary
Fig. 1E). Quantitative PCR (qPCR) analysis showed that changes
in metabolites correlated with upregulation of glycolytic genes in
both WT and Nos2−/− (Supplementary Fig. 1F). Citrate, cis-
aconitate, succinate, and itaconate accumulated in LPS-treated
WT, while α-KG declined (Fig. 1c), the latter indicator of the
reported “break” in the TCA cycle26. In Nos2−/−, itaconate levels
were higher than WT, and succinate accumulated whereas citrate
did not (Fig. 1c) and the decline in α-KG was absent.
Reduced α-KG is indicative of the TCA break, but not
deﬁnitive proof. Therefore, we performed stable isotopic labeling
using uniformly labeled 13C-glucose ([U-13C]) in untreated and
LPS/IFNγ-stimulated WT and Nos2−/− BMDMs. Taking into
account the total amount of citrate synthesized from glucose as
pyruvate-derived acetyl-CoA enters the TCA (m+ 2 isotopolo-
gues, Fig. 1d), WT macrophages showed little cis-aconitate and
almost no α-KG derived from 13C citrate, conﬁrming TCA break
(Fig. 1e). Importantly, activated Nos2−/− did not exhibit any
apparent break, as proportions of 13C-glucose-derived α-KG were
similar to that of unstimulated cells. This effect was most evident
when expressed as ratios of 13C citrate to α-KG (Fig. 1f). As a
result, m+ 2 glutamate, succinate, fumarate, malate and m+ 1
itaconate were barely detectable in stimulated WT (Fig. 1g).
Taken together, our results indicate intact glycolytic and TCA
machinery in Nos2−/− macrophages, regulation of itaconate
production by NOS2, and a role for NO in citrate accumulation
during inﬂammatory macrophage polarization.
Metabolic changes have been suggested to be critical in the
development of inﬂammatory macrophages2. As we ﬁnd that
Nos2−/− fail to undergo large scale mitochondrial meta-
bolic rewiring, we expected their ability to differentiate into
inﬂammatory macrophages to be impaired. Surprisingly,
transcriptional proﬁling of stimulated Nos2−/− macrophages
showed upregulated genes (Fig. 1h) enriched in pathways
related to cytokine production and establishment and main-
tenance of the inﬂammatory response (Table 1 and Supple-
mentary Table 1) while regulation of M2-associated genes27–29
was unaffected by the absence of NO (Supplementary Fig. 1G).
Assessment of secreted inﬂammatory mediators conﬁrmed
enhanced inﬂammatory state of Nos2−/− macrophages, includ-
ing increased production of IL1β, IL6, IL12p40, macrophage
inﬂammatory protein-α (MIP1α/CCL3) and monocyte che-
moattractant protein-1 (MCP1/CCL2). Tumor necrosis factor
(TNFα), IL10, and chemokine C-X-C motif ligand-1 (KC/
CXCL-1) production was unaffected (Fig. 1i).
In addition, gene ontology enrichment analysis showed lower
expression of nuclear factor erythroid 2-related factor 2 (Nrf2)
target genes in absence of NOS2 (Table 1), suggesting that while
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Fig. 1 Nos2−/− macrophages show intact metabolism and inﬂammatory machinery. Heat-maps of the log10 ratio from the average peak areas from Gas
Chromatography-Mass Spectrometry (GC-MS) analysis of metabolites associated with the arginine metabolism (a), glycolysis (b), and citric acid cycle (c)
from bone marrow-derived macrophages (BMDMs) from wild-type (WT) and Nos2−/− mice activated with LPS for 24 h compared to unstimulated (ctrl).
d Schematic illustration of atom transitions in central metabolism using uniformly labeled 13C-glucose ([U-13C]) (labeled carbons are indicated in blue) as
tracer for determination of mass isotopologue distributions (MID) to infer relative intracellular ﬂuxes through oxidation of pyruvate. PDH pyruvate
dehydrogenase, ACO2 aconitase 2, IDH isocitrate dehydrogenase, OGDH oxoglutarate dehydrogenase, SDH succinate dehydrogenase, FH fumarate
hydratase, MDH malate dehydrogenase. e–g WT and Nos2−/− BMDMs were activated with LPS+ IFNγ and cultured with labeled tracer. Bars show
evaluation of the [U-13C] glucose-derived carbon incorporation (percentage) into m+ 2 isotopologues of the indicated TCA intermediates. e Percentage of
13C in m+ 2 isotopologues of cis-aconitate (cis-aco) and α-ketoglutarate (α-kG). f Bar graph depicting the ratio between citrate and α-kG for 13C fraction of
the total metabolite level. g m+ 2 isotopologues of glutamate (glu), succinate (succ), fumarate, malate and in m+ 1 itaconate (ita) in activated WT and
Nos2−/− BMDMs. Data in a–c (n= 5 biological replicates per group) and e–g (n= 6) were analyzed by two-way ANOVA (interaction < 0.0001) (Sidak’s
post-tests). h Expression proﬁle of selected inﬂammatory genes from microarray analysis (see Table1) shown as heatmap of log2 fold changes of LPS+
IFNγ-stimulated Nos2−/− BMDMs compared to WT (n= 3). I The concentration of IL1β, IL6, IL12p40, TNFα, IL10, MCP1, MIP1α, and KC secreted into the
culture media when BMDMs were stimulated for 24 h. Data are pooled from three experiments (n= 7–8) and were analyzed by two-way ANOVA with
Sidak’s post-tests. All error bars display mean ± SEM. Source data are provided as a Source Data ﬁle.
NATURE COMMUNICATIONS | https://doi.org/10.1038/s41467-020-14433-7 ARTICLE
NATURE COMMUNICATIONS |          (2020) 11:698 | https://doi.org/10.1038/s41467-020-14433-7 | www.nature.com/naturecommunications 3
polarization of WT macrophages elicits an anti-oxidant response,
stimulation of Nos2−/− cells does not.
The TCA Break is due to NO targeting of mitochondrial
aconitase. Previous reports have suggested that the TCA break is
due to downregulation of Idh126. Having determined that the
break is NOS2 dependent, we investigated possible mechanisms
for this process. Consistent with other studies, we detected a
decline in Idh1 mRNA in stimulated macrophages (Fig. 2a), but
in contrast to the TCA break, this was NOS2 and NO-
independent (Fig. 2a and Supplementary Fig. 2A, B). Accord-
ingly, the iNOS inhibitor Aminoguanidine (AG) had no effect on
IDH enzymatic activities (Supplementary Fig. 2C).
In contrast to IDH1, mitochondrial aconitase (ACO2) is a known
target of NO22,24. Therefore, we tested the possibility that NO-
mediated suppression of ACO2, rather than IDH1, might be
responsible for the TCA break. Although aconitase mRNA levels
were not affected by LPS/IFNγ (Supplementary Fig. 2D), WT M1
BMDMs had reduced protein levels of ACO2 (Fig. 2b). Moreover,
LPS/IFNγ or direct application of the NO donor DETA/NO to
resting cells substantially reduced ACO2 enzymatic activity without
affecting cytosolic ACO1 (Fig. 2c–e). ACO2 activity remained
unchanged in stimulated Nos2−/− (Fig. 2c) and in WT cells in the
presence of AG (Fig. 2e). Finally, addition of NO donor to cultures
of stimulated Nos2−/− macrophages was sufﬁcient to decrease
ACO2 activity in concentration dependent manner (Supplementary
Fig. 2E). Consistent with NO-suppressing ACO2 through disrup-
tion of its iron-sulfur cluster [Fe4-S4]24,30, treatment with ferrous
iron (Fe2+) and reducing agents reconstituted ACO2 (Supplemen-
tary Fig. 2F). To further conﬁrm the break at ACO2, we used direct
fueling of permeabilized macrophages. Supplying stimulated
WT cells with citrate (state 3 respiration) diminished respiration
as compared to resting macrophages (Fig. 2f and Supplementary
Fig. 2G). However, addition of isocitrate increased OCR, indicating
that the TCA break is upstream of isocitrate. In addition, stimulated
Nos2−/−, or WT macrophages treated with AG, maintained the
ability to respire citrate (Fig. 2f, g and Supplementary Fig. 2G). To
prove the impact of ACO2 inhibition on the TCA, we stimulated
Nos2−/− in the presence of the aconitase inhibitor ﬂuoroacetate
(FA)31 (Supplementary Fig. 2H). After conﬁrming intracellular
delivery of FA (Supplementary Fig. 2I), we observed FA-dependent
citrate and cis-aconitate accumulation together with decreased
α−KG (Fig. 2h). Moreover, pharmacologic inhibition of ACO was
sufﬁcient to decrease respiration (Fig. 2i and Supplementary Fig. 2J).
Interestingly, the magnitude of these changes only partially mirrors
the effect of DETA/NO as ACO blockade alone did not affect
itaconate or succinate and was not sufﬁcient to decrease down-
stream TCA intermediates (Fig. 2h and Supplementary Fig. 2K).
Altogether these data unequivocally show that ACO2 rather
than IDH1 is the TCA breakpoint in M1 macrophages, that this is
responsible for increases in citrate and reductions in α−KG, and
that NO is necessary and sufﬁcient to mediate these effects.
Moreover, detection of rotenone sensitive, isocitrate-mediated
respiration (Fig. 2f, g) indicated that CI, CIII, and CIV of the ETC
were still functional even after over-night stimulation.
Absence of NO promotes pyruvate oxidation via PDH. To
investigate potential roles for NO in more proximal metabolic
reprogramming than the TCA break we carried out detailed 13C
tracing experiments. 1H-{13C} heteronuclear single-quantum
coherence (HSQC) nuclear magnetic resonance (NMR) spectra
conﬁrmed glycolytic shifts (Fig. 3a and Supplementary Fig. 3A)
and showed that labeled TCA cycle-derived metabolites (e.g., Glu
and Asp) were higher in Nos2−/− compared to WT macrophages,
suggesting NOS2-dependent suppression of 13C-glucose entry
into the TCA during polarization. Furthermore, NMR revealed
amounts of 13C labeled itaconate in Nos2−/−, consistent with the
notion that cells lacking NOS2 have both intact TCA and active
cis-aconitate decarboxylase.
Deeper analysis of 13C by MS revealed more profound effects
of NO on carbon ﬂow. We observed reduced m+ 2 citrate
enrichment in stimulated WT compared to Nos2−/− macro-
phages (Fig. 3b). Mass isotopologue distribution (MID) of citrate
refers to m+ 2 and m+ 3 isotopologues as results of the initial
entry of glucose into the TCA via pyruvate dehydrogenase (PDH)
or pyruvate anaplerosis, respectively. m+ 4, m+ 5 and m+ 6
isotopologues indicate 13C-glucose-derived carbons that have
cycled two or more times through the TCA (Supplementary
Fig. 3B). In fact, fractional enrichment of 13C into m+ 2 citrate in
Nos2−/− was largely unaffected by stimulation whereas in WT
~90% of citrate remained unlabeled (m+ 0), indicating that it
was not derived from glucose. This differential labeling in WT vs.
Nos2−/− was reﬂected in other TCA metabolites (Fig. 3c–i and
Supplementary Fig. 3A). In addition, Nos2−/− macrophages had
higher levels of m+ 4 isotopologues demonstrating higher
glucose oxidation through multiple rounds of an intact TCA
(Fig. 3c–i).
Interestingly, Nos2−/− showed comparable enrichment in
m+ 3 citrate, cis-aconitate and malate to that seen in WT cells
(Fig. 3b, c, i). m+ 3 citrate and m+ 3 malate derive from m+ 3
oxaloacetate (OAA) produced by pyruvate carboxylation followed
by condensation with unlabeled acetyl-CoA (citrate) or free
exchange via MDH (malate). Surprisingly WT macrophages had
more m+ 3 aspartate (Supplementary Fig. 3C), produced by
transamination of OAA (Fig. 1d). Of note, we found higher
induction of pyruvate carboxylase (PC, Pcx) during stimulation of
WT compared to Nos2−/− (Supplementary Fig. 3D, E). This
suggest that alternative pathway promoting anaplerosis through
PC may be upregulated. Consistent with functional aconitase,
m+ 3 isotopologues downstream of cis-aconitate were increased
in Nos2−/− (Fig. 3e–h).
These data suggest NO-dependent blockage of glucose oxida-
tion via PDH- but not PC-initiated TCA. Thus, we calculated the
ratio of m+ 2 citrate/m+ 3 pyruvate to normalize for upstream
Table 1 Enriched canonical pathways of differentially expressed genes.
Canonical pathway z-score p-value Associated gene number
NF-κB signaling 3.207 2.40E-05 14
Acute phase response signaling 2.887 2.24E-05 14
Role of IL17F in allergic inﬂammatory airway diseases 2.449 4.07E-05 7
Toll-like receptor signaling 1.342 3.09E-05 9
TNFR2 signaling 1.000 3.09E-05 6
NRF2-mediated oxidative stress response −1.069 7.41E-06 32
Ingenuity pathway analysis (IPA) of the score for the likelihood that genes belonging to a speciﬁc canonical pathway category were different after 8 h of LPS+ IFNγ stimulation of Nos2−/− and WT
BMDMs. Positive or negative z-score value indicates that a function is predicted to be increased or decreased in Nos2−/− relative to WT activated cells. The signiﬁcance of canonical pathways was
determined by IPA’s default threshold [–log (p-value) > 1.3] (p < 0.05). The associated gene number represents the number of differentially expressed genes involved in the respective canonical pathway.
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changes in glycolysis13 and found low ratios only in stimulated
WT (Fig. 3j). This ﬁnding, together with decreased acetyl-CoA
availability (Supplementary Fig. 3F), conﬁrmed NOS2-dependent
decreased pyruvate ﬂux through PDH. Moreover, we found that
LPS/IFNγ-induced reductions in pyruvate-elicited respiration
were dependent on NOS2 and NO (Fig. 3k and Supplementary
Fig. 3G).
Decreased carbon ﬂux through PDH is Hif1α independent.
Decreases in pyruvate oxidation have been suggested to result
from HIF1α-mediated pyruvate dehydrogenase kinase 1 (Pdk1)
induction, with subsequent phosphorylation and inactivation of
PDH by PDK132–34. Since we did not observe decreased m+ 2
citrate in macrophages lacking NOS2, we investigated possible
NO effects on HIF1α. We found that stimulation resulted
in increased Hif1α and Pdk1 levels in both WT and Nos2−/−
macrophages (Fig. 4a and Supplementary Fig. 4A, B). Further-
more, we found considerable levels of PDK1 and phospho-PDK1
in resting cells, consistent with high-glycolytic status of
murine BMDMs35, and these levels remained unchanged after
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Fig. 2 The TCA Break is due to NO targeting of mitochondrial aconitase. a WT and Nos2−/− BMDMs were stimulated for 8 h and mRNA was extracted
from total cell lysates and analyzed by qPCR for Idh1 (n= 6) (two-way ANOVA, Sidak’s post-tests; p-values= 0.033, 0.0093). b Whole-cell lysates of
macrophages derived from two independent WT and Nos2−/− mice were analyzed by western blot for cytosolic and mitochondrial aconitase (ACO 1-2).
β-actin was used as loading control. c, d Aconitase 2 and total aconitase (aconitase 1) enzymatic activities in WT vs. Nos2−/− BMDMs stimulated over
night (O.N.). Where indicated cells were treated with NOS2 inhibitor Aminoguanidine (AG) 1 h prior to stimulation (n= 6). e Damaging effect of
endogenously produced or exogenously provided NO (DETA/NO) on activity of aconitase 2 (n= 3). f Representative Seahorse analysis of oxygen
consumption rates (OCR) in permeabilized WT and AG-pretreated BMDMs stimulated O.N. Citrate, tartronate, ADP and PMP were co-injected (ﬁrst event
marker). Isocitrate was injected at the second event marker and rotenone (rot) was injected lastly. g Quantiﬁcations (percentage relative to ctrl cells)
of exogenous citrate and isocitrate-dependent state 3 OCR in WT vs. Nos2−/− (n= 6). Data were analyzed by one-way (c–e) or two-way ANOVA (f, g),
(p < 0.0001) with Tukey’s post-tests. h Nos2−/− BMDMs were stimulated with LPS+ IFNγ in the presence of either DETA/NO (500 μM) or FA.
Metabolites were quantiﬁed by ESI-LC/MS-MS and are reported as normalized total ng or peak area. Data (n= 6) were analyzed by one-way ANOVA with
Dunnett’s post-tests. i Bar graphs showing quantiﬁed, protein normalized, basal OCR from stress tests of Nos2−/− macrophages treated with vehicle or FA
1 h prior to O.N. stimulation. Data (n= 3) were analyzed by two-way ANOVA with Sidak’s post-tests. All error bars display mean ± SEM. Source data are
provided as a Source Data ﬁle.
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stimulation (Supplementary Fig. 4C). Accordingly, activation did
not change phosphorylation status of PDH (Fig. 4b) and treat-
ment with PDK inhibitor dichloroacetate (DCA) had no effect
on OCR (Supplementary Fig. 4D). In addition, OCR decrease in
M1-polarized Hifα−/− macrophages was comparable to that of
WT, and we detected equivalent ECAR levels in WT and Hifα−/−
macrophages (Fig. 4c), despite HIF1α-mediated regulation of
glycolytic genes (Supplementary Fig. 4E, F). Metabolomic
proﬁling of Hifα−/− BMDMs showed levels of LPS/IFNγ-induced
glycolytic intermediates, citrate, itaconate and α-KG comparable
to WT, indicating that Hif1α−/− BMDMs still have a block in
the TCA at ACO2 (Fig. 4d). In further support of this, we
found citrate-fueled respiration equally impaired in Hif1α−/− and
WT macrophages (Supplementary Fig. 4G). Pyruvate-dependent
respiration was still compromised in Hif1α−/− cells (Fig. 4e), and
PDK1 protein was unaffected (Supplementary Fig. 4H). Lastly, we
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pharmacologically manipulated HIF1α in WT and Nos2−/−
macrophages with dimethyl α-KG (Dα-KG) or dimethylox-
alylglycine (DMOG). Treatment with Dα-KG, a prolyl hydro-
xylase (PHD) agonist, did not improve respiration (Fig. 4f) and
had no effect on glycolysis (Supplementary Fig. 4I) or expression
of Pdk1 or Pcx (Fig. 4g and Supplementary Fig. 4J). Interestingly,
direct targeting of PHDs via the inhibitor DMOG, promoting
HIF1α stabilization, strongly skewed OCR/ECAR towards gly-
colysis in resting WT and Nos2−/− (Fig. 4h), suggesting that
boosting the amount of HIF1α increases glycolytic activity by
affecting Pdk1 expression regardless of activation (Supplementary
Fig. 4K). Finally, when fueling with pyruvate, OCR after DMOG
was similar to vehicle, conﬁrming that inhibition of pyruvate
respiration in activated macrophages is solely dependent on NO
production (Supplementary Fig. 4L).
Having excluded the Hif1α-mediated mechanism of PDH
inhibition, we tested whether this was the result of product
inhibition due to blockade of ACO2. We found that this was not
the case as ﬂuoroacetate (FA)31 did not affect pyruvate respiration
(Supplementary Fig. 4M). We then hypothesized that PDH might
be directly inhibited in the presence of NO. Therefore, we
assessed PDH enzymatic activity and found nearly undetectable
activity in stimulated WT cells (Fig. 4i), so we used native in-gel
activity assays to further investigate the mechanism. These data
revealed decreased activity of the PDH-E3 subunit (dihydrolipoyl
dehydrogenase, DLD) accompanied by shifts in in-gel migration
in activated WT compared to Nos2−/− macrophages (Fig. 4j),
suggesting the presence of post-translational modiﬁcation. We
then immunoprecipitated DLD and detected strong reactivity in
immunoblots (IBs) for anti Cysteine-SNO only in activated
WT cells (Fig. 4k).
Taken together, these data demonstrate that during polariza-
tion Hif1α does not control macrophage mitochondrial metabolic
reprogramming via PDK-mediated modulation of PDH activity,
rather NO-dependent suppression of PDH occurs, likely via
S-nitrosation of DLD.
LPS/IFNγ increase glutamine utilization in NO-dependent
manner. Having demonstrated NO-dependency of decreased
pyruvate oxidation through PDH and disruption of TCA
cycle (Fig. 3, 4), we next asked whether the accumulation of citrate
and other TCA metabolites (Fig. 1c) might reﬂect utilization of
carbon sources other than glucose. Since glutaminolysis is a major
anaplerotic pathway in macrophages36, we tested if this might
be activated to compensate for ACO2 and PDH malfunction in
stimulated cells. Measurement of extracellular glutamine levels
revealed NOS2-dependent uptake of glutamine (Fig. 5a and
Supplementary Fig. 5A, B). [U-13C]-glutamine tracing showed
that, despite comparable upregulation of glutaminase (Fig. 5b and
Supplementary Fig. 5C), 13C fractions of glutamate, succinate and
citrate were smaller in macrophages lacking NOS2 (Fig. 5c), which
displayed higher fraction of unutilized [U-13C] glutamine (Sup-
plementary Fig. 5D). These data indicate a major contribution of
glucose to metabolite pools in macrophages lacking NOS2.
Moreover, in WT cells 51% of the succinate was labeled but only
~10% of fumarate contained 13C, suggesting that only small
amounts of 13C succinate transit via SDH and that alternative
routes yield fumarate and malate in stimulated WT26,37. In con-
trast, in Nos2−/− cells a higher percentage of carbon transited
through SDH (Fig. 5c). Blocking ACO2 with FA, in absence of
NO, promoted increased glutamine utilization and elicited a
greater enhancement of OCR in the presence of glutamine (Fig. 5d
and Supplementary Fig. 5E), conﬁrming switch toward glutami-
nolysis to sustain mitochondrial metabolism when glucose-derived
substrates are lacking.
Taken together, these data demonstrate that during LPS/IFNγ
treatment the presence of NO induces uptake of glutamine and its
utilization due to the cessation of glucose ﬂux via PDH and
ACO2. Concomitantly, SDH activity falls in an NO-dependent
manner and carbon is re-routed. These data emphasize the ability
of macrophages to adapt to NO production through exploitation
of alternative pathways to satisfy the need for bioenergetics
substrates.
NO inhibits mitochondrial ETC complexes and promotes their
loss. Older studies had suggested that NO might directly target
and inactivate mitochondrial respiratory chain21,24,38. Therefore,
having ruled out NO effects on mitochondrial number per se
(Supplementary Fig. 6A), we performed native IBs to assay the
integrity of ETC (Fig. 6a). Our analysis revealed profound
stimulation-dependent reduction of supercomplexes containing
CI plus dimerized CIII, levels of CIII, and free CI, CII, and CIV in
WT but not in Nos2−/− macrophages (Fig. 6a). Next, we per-
formed sodium dodecyl sulfate (SDS) IBs and detected NOS2-
dependent reductions in CI (NDUFS1), CII (SDHB), CIII
(UQCRC2), and CIV (MTCO1) subunits (Fig. 6b), which suggest
that changes in abundance of supercomplexes are due to changes
in protein expression and not simply alterations in supercomplex
formation.
In-gel NADH-dehydrogenase assays conﬁrmed Nos2-
dependent decline in CI activity in BMDMs after stimulation
(Fig. 6c). Similarly, CII and CIV activities were progressively
Fig. 4 Decreased carbon ﬂux through PDH is Hif1α independent. a Immunoblot (IB) for HIF1α protein of three independent nuclear extracts from WT
and Nos2−/− BMDMs stimulated for 24 h. Lamin B was used as loading control (n= 6). b IB for PDH-Phospho-Ser293 in mitochondrial extracts; citrate
synthase (CS) was used as loading control (n= 6). c O.N.-treated WT and Hif1α−/− BMDMs were seeded in Seahorse XF96 cell culture plates and
sequential treated with oligomycin (Oligo), FCCP, and rotenone plus antimycin A (Rot/AA). Basal OCR and extracellular acidiﬁcation rate (ECAR) are
quantiﬁed (n= 3). Data were not signiﬁcant by two-way ANOVA with Sidak’s post-tests (p-values= 0.59, 0.1675). d Heat-maps from GC-MS analysis of
metabolites of glycolysis and TCA cycle from Hif1α−/− BMDMs. Data show log10 ratio from the average peak areas of stimulated cells compared to
unstimulated. Data (n= 4) were analyzed by two-way ANOVA (interaction < 0.0001) (Sidak’s post-tests). e Representative Seahorse analysis of
pyruvate/malate respiration in WT and Hif1α−/− BMDMs. Bar graphs show quantiﬁed OCR (n= 3) (two-way ANOVA, interaction p= 0.036, Sidak’s post-
tests). f Protein normalized basal OCR from stress tests of WT and Nos2−/− macrophages treated with Dimethyl α-KG (D-αkG) 1 h prior to O.N.
stimulation. Data were analyzed by Student’s t-test (n= 3). g BMDMs as in f and stimulated for 8 h. mRNA from total cell lysates was analyzed by qPCR
for Pdk1. Data (n= 6) were not signiﬁcant by two-way ANOVA (interaction p= 0.74) (Sidak’s post-tests). h Basal OCR/ECAR in WT and Nos2−/−
BMDMs stimulated O.N. and pretreated with DMOG. Data (n= 3) were analyzed by two-way ANOVA (interaction < 0.0001) (Sidak’s post-tests).
i Enzymatic activity of PDH in total cell lysates from WT and Nos2−/− BMDMs after O.N. activation. Data (n= 6) were analyzed by unpaired t-test with
Welch’s correction (p= 0.0038). j PDH-E3 (DLD) in-gel activity assay and IB on native gels of mitochondrial fractions from macrophages from two
independent WT and Nos2−/− mice. k Mitochondrial fractions from control and LPS+ IFNγ stimulated WT and Nos2−/− BMDMs were used as inputs to
immunoprecipitate DLD. Anti DLD and Anti-CysSNO IBs were performed. All error bars display mean ± SEM. Source data are provided as a Source
Data ﬁle.
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decreased, whereas they remained unchanged in Nos2−/− (Fig. 6d,
e). Furthermore, stimulated Nos2−/− cells treated with the NO
donor had dysfunctional CI and CII (Fig. 6f, g). Moreover,
protein levels and activity of CI and CII, as well as CI to CIV of
WT macrophages is rescued completely by the presence of AG
before or halfway through stimulation (Supplementary Fig. 6B).
Altogether these experiments proved concretely the link between
NO and macrophage ETC impairment.
The concomitant decrease in the activity of CI, CII and CIV
together with the intact OCR of stimulated WT macrophages
upon direct substrate feeding (Fig. 2f, g and Supplementary
Fig. 6C, D), suggest that if were electron donors available,
remaining ETC complexes are sufﬁcient to compensate for
NO-dependent loss.
NO directs metabolic reprogramming in vivo. To address
whether, similar to that observed in activated BMDMs in vitro,
nitric oxide was involved in macrophage metabolic reprogram-
ming in inﬂammatory conditions in vivo we assessed metabolism
during a modiﬁed Schwartzman reaction39.
Mice were given thioglycolate intraperitoneally (i.p.) 3 days
before priming with IFNγ, then challenged with LPS (Fig. 7a).
This reaction yielded increases in nitrite and citrulline in the
peritoneal lavage (Fig. 7b and Supplementary Fig. 7A) indicating
substantial iNOS activity. Moreover, we conﬁrmed that like
BMDMs in vitro, during the Schwartzman reaction, peritoneal
CD11b+ Ly6G−macrophages were prominent producers of
citrulline (Fig. 7c), accumulated itaconate (Fig. 7d) and had
decreased ornithine (Fig. 7e). Furthermore, consistent with
in vitro ﬁndings, CD11b+ Ly6G−macrophages from the
peritoneum showed increased citrate to isocitrate ratios (Fig. 7f
and Supplementary Fig. 7B) and reduced α-KG (Fig. 7g and
Supplementary Fig. 7C) indicative of ACO2 blockade. Accord-
ingly, we observed decreased aconitase 2 activity in total
CD11b+ cells isolated during peritoneal inﬂammation conﬁrm-
ing this relationship (Fig. 7h).
Although these parameters recapitulated many in vitro ﬁndings,
in vivo macrophages did not show increases in absolute intracellular
quantities of citrate during the Shwartzman reaction (Supplemen-
tary Fig. 7D). However, citrate increased in the lavage ﬂuid (Fig. 7i)
as did citrate/α- KG ratios and itaconate; ornithine levels dropped.
In vivo macrophages also showed indications of anaplerosis, with
glutamine inﬂux and glutamate usage, despite apparent highly
controlled absolute levels of glutamine and glutamate in the lavage
(Fig. 7j and Supplementary Fig. 7E). Remarkably, we found that
all these characteristics were dependent on Nos2, as lavage from
Nos2−/− mice under these same conditions not only displayed
increased arginine metabolites apart from Nos2 activity (Fig. 7i
and Supplementary Fig. 7E), but also excessive itaconate and no
increase in citrate (Fig. 7i). Intracellularly, peritoneal Nos2−/−
macrophages showed absence of break at ACO2, restored succinate
and malate levels, and weaker glutamine-derived carbon usage
(Fig. 7j).
Finally, we analyzed the function of CI and CII components of
mitochondrial ETC of CD11b+ cells isolated from mice under-
going Shwartzman reaction and found that these were
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considerably compromised in NOS2-dependent manner, similar
to BMDMs (Fig. 7k).
Taken together, these data show that not only do many
characteristics of macrophage metabolic rewiring recapitulate
in vivo, but these are almost universally dependent on NO.
Discussion
Glycolytic commitment, characterized by downregulation of
OXPHOS and ATP production by mitochondria is a key feature in
the response of macrophages and DCs to proinﬂammatory sti-
muli40. Current models suggest that rewiring of carbon utilization
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takes place through the coordinated suppression of IDH1, SDH,
and the PDH complex4,10,11,26,32. This model predicts that mac-
rophages primarily convert glucose-derived pyruvate to lactate,
while anaplerotic glutaminolysis facilitates succinate accumulation,
which yields Hif1α stabilization, leading to IL1β production and
suppression of PDH via Pdk12,4,10,11,26,32. Our study calls for
reconsideration of this proposed model. We provide evidence for
NO being the main orchestrator of changes in macrophage mito-
chondrial metabolism during exposure to inﬂammatory stimuli
(Fig. 8).
One of the most profound macrophage alterations is reduction
in carbon ﬂow from citrate to α-KG and concomitant decline in
α-KG levels. Jha et al. suggested that this break in the TCA was
due to transcriptional downregulation of Idh126. However. we
demonstrate that lack of carbon continuity between citrate and α-
KG and declines in α-KG are results of NO production. We ﬁnd
that although NOS2 is required for alterations in α-KG home-
ostasis, it is dispensable for reductions in Idh1 mRNA. IDH1 is a
cytoplasmic enzyme and less likely to direct affect TCA function.
In contrast, multiple lines of evidence suggest that ACO2 is
the source of TCA break. Unlike IDH1, ACO2 is a known target
of NO attack22,24,30, and we document reductions in ACO2
protein and activity during polarization. Most importantly, our
studies show that citrate-mediated respiration is blunted in M1
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macrophages whereas isocitrate respiration is intact, deﬁnitively
placing the break at ACO2 not IDH1. This is the ﬁrst demon-
stration that ACO2 is the metabolic target in BMDMs. In addi-
tion, speciﬁc inhibition of ACO2 is in accordance with known
lipophilic nature of NO chemistry22.
Although alterations in TCA are considered to be vital for
appropriate immune response2,9 it is interesting to note that, as
reported also by others41–43, Nos2−/− macrophages maintained
full inﬂammatory phenotype, as indicated by higher inﬂamma-
tory gene expression and cytokine secretion than WT. Our
ﬁndings suggest that in Nos2−/− cells, a functional TCA and
better stabilization of Keap1 (Kelch-like ECH-associated protein
1), regulator of Nrf2, could prevent Nrf2-mediated inhibition of
transcription. Nrf2 is known to attenuate inﬂammation in mye-
loid cells44, and our data suggest that the presence of NO
reprograms macrophage metabolism while promoting protective
processes to mitigate NO-induced damage, at the expense of full
inﬂammatory responses. This is in line with the impact of NO in
DCs in limiting adaptive immune cell activation42.
We demonstrate that carbon ﬂux through the PDH complex is
severely compromised in M1 macrophages. Reports have sug-
gested that in polarized macrophages, pseudo-hypoxia, caused by
reduction in α-KG /succinate ratios, results in Hif1α stabilization
and expression of Pdk1, that phosphorylates PDH, reducing
pyruvate oxidation and promoting Warburg effect2,4,32,34,45. In
contrast, we support a different mechanism for this phenomenon.
Although 13C tracing studies do show cessation of glucose carbon
ﬂux through PDH, we ﬁnd this effect to be dependent on NO
production, while Hif1α stabilization, PDK accumulation, and
PDH phosphorylation are independent of NOS2. Moreover,
PDK1 expression, the TCA break and compromised PDH activity
were all evident in macrophages lacking Hif1α, consistent with
the data from Prados et al.46. Our data suggest that NO directly
targets PDH as we found the DLD subunit to be inactive and
positive for cysteine-nitrosation in NOS2-dependent manner.
This hypothesis is supported by reports of nitrosation of the
PDHE3 subunit by nitroxyl or peroxynitrite47,48. Therefore,
instead of Hif1α/PDK-mediated effect, we propose that N2O3 or
nitrogen dioxide NO2, from reaction of NO with oxygen, directly
inactivates PDH. The fact that DLD is targeted by NO has
implications due to its association with multiple metabolic
enzymes, including oxoglutarate dehydrogenase (OGDH) and
branched chain alpha keto acid dehydrogenase (BCKDH). Thus,
we predict that OGDH and BCKDH, like PDH, are stalled due to
NO-mediated injury. This requires further biochemical dissection
but suggests that additional NO-mediated rewiring events are yet
to be discovered.
NO affects the accumulation of metabolites hallmarks of M1
polarization: citrate, succinate and itaconate. Our data support a
model in which, during stimulation, glucose uptake increases,
Fig. 7 NO directs metabolic reprogramming in vivo. a Mice were injected i.p. with thioglycolate and challenged after 3 days with injections of IFNγ or
PBS i.p. 12 h later, mice were administered LPS i.p. and euthanized in the subsequent 12 h. Peritoneal lavage ﬂuid was harvested and cells isolated:
both processed for metabolic studies. b Nitrite levels were quantiﬁed by Griess reaction performed on concentrated lavage ﬂuid in comparison with
2 × 106 LPS/IFNγ stimulated BMDM-derived culture media. Results are shown as total nmol. (n > 3 for each group). c Mice were challenged as in a and
either Ly6G+ or Cd11B+ cells were isolated from peritoneal lavage and subjected to metabolite extraction and subsequent ESI-LC/MS-MS analysis.
Normalized peak area of citrulline is shown. d–g Quantiﬁed metabolites in Cd11b+ Ly6G- isolated from WT mice challenged for Shwartzman reaction
(n= 6) (“t” represents mice injected with thioglycolate alone). h Aconitase 2 activity in total CD11b+ cells from mice undergoing Shwartzman reaction
(n= 3). Data were analyzed by Student’s t-test. i WT and Nos2−/− mice were challenged as in a and peritoneal lavage was concentrated, extracted and
analyzed by ESI-LC/MS-MS analysis. Absolute amounts as ng/total μg protein in lavage ﬂuid are shown. Data were analyzed by two-way ANOVA with
Sidak’s post-tests (n= 8). Shown p-values indicate WT vs. Nos2−/− comparisons in IFNγ+ LPS condition. j Quantiﬁed metabolites in Cd11b+Ly6G−
isolated from challenged WT and Nos2−/− mice. The dotted line represents the average level of metabolite in thioglycolate alone-group. Data were
analyzed by Student’s t-test (n= 3). k CI in gel activity and SDS IBs for CI (NDUFS1) and CII (SDHA) in total CD11b+ cells from challengedWT vs. Nos2−/−
mice (n= 2). Source data are provided as a Source Data ﬁle.
I
II
III
IV
Glycolysis
Carboxylation
Glucose
TCA Cycle
Acetyl-CoA
Lactate
Pyruvate 
Citrate 
Cis-aconitate
Isocitrate
α-ketoglutarate 
Succinate
Oxaloacetate Itaconate
Glutamate Glutamine
Aspartate
Glutaminolysis
PDH NO
ACO2
ACO2
IDH
I
II
III
IV
NADH
Glycolysis
Glucose
TCA Cycle
Acetyl-CoA
Lactate
Pyruvate 
Citrate 
Cis-aconitate
Isocitrate
α-ketoglutarate 
Itaconate
Glutamate Glutamine
Glutaminolysis
PDH
ACO2
ACO2
IDH
Glucose
GlutamineWT NOS2 –/–
M1 (LPS/IFN) MØ
Fig. 8 NO orchestrates metabolic reprogramming in M1 macrophages. Macrophage activation in the presence of Nitric Oxide (NO) results in multiple
metabolic rewirings. Aconitase 2 is inhibited and entrance of carbon into TCA cycle via pyruvate dehydrogenase is halted. In turn, compensatory
carboxylation and glutaminolysis are enhanced, leading to citrate accumulation and limited itaconate. Because of the breaks, the lack of NADH and reduced
substrates leads to inactive mitochondrial complexes. In Nos2−/− BMDMs glycolytic ﬂux is maintained and carbon passage through PDH and ACO2 is
intact. In this scenario, production of itaconate is increased and mitochondrial complexes display full functional activity. The arrows represent the general
direction of the metabolic ﬂow in the system with the speciﬁc contribution of glucose (purple) and glutamine (green). PDH pyruvate dehydrogenase, ACO2
mitochondrial aconitase, IDH isocitrate dehydrogenase, LPS lipopolysaccharide, IFNγ interferon γ.
ARTICLE NATURE COMMUNICATIONS | https://doi.org/10.1038/s41467-020-14433-7
12 NATURE COMMUNICATIONS |          (2020) 11:698 | https://doi.org/10.1038/s41467-020-14433-7 | www.nature.com/naturecommunications
Irg1 is induced and citrate and itaconate are synthesized incor-
porating glucose-derived carbon. When NO levels rise, PDH
suppression limits further utilization of glucose carbon resulting
in increased compensatory glutamine inﬂux that routes carbon
through TCA to yield citrate and itaconate. As NO levels suppress
ACO2 activity, citrate accumulates and is exported, whereas ita-
conate production is limited due to the lack of cis-aconitate. This
is supported by the very rapid detection of itaconate14, the higher
levels of itaconate in Nos2−/−, the sensitivity of PDH and ACO2
to direct NO inhibition, and the substantial incorporation of
glucose carbon into itaconate in Nos2−/−, whereas in WT it is
largely unlabeled. Importantly, while availability of cis-aconitate
supports production of itaconate, Irg1 only negligibly affects cis-
aconitate compared to the effect elicited by NO on ACO2.
Moreover, GABA shunt itself may represent an effort to bypass
suppression of OGDH.
Our data demonstrate that NO leads to the decline in the levels
of mitochondrial ETC complexes, a phenomenon that has not
been fully described and often overlooked in M1 macrophages.
We conﬁrmed that NO is sufﬁcient and iNOS is required.
Our experiments with permeabilized cells suggest that when
directly fueled in vitro, M1 macrophages can still carryout CI
(isocitrate-elicited) and CII (succinate-based) respiration even
when exposure to NO has reduced protein levels, suggesting that
the remaining complexes are operational, and thus inoperative
spare complexes have been removed. The inhibition of CI and II
of mitochondrial ETC has been thought to result from
S-nitrosation of thiols in these protein complexes49,50. However,
It is known that absence of substrates favors the conversion of CI
to its deactivated (D) form, which has exposed cysteines targets of
nitrosation and/or oxidation51,52. The D form comprises a sig-
niﬁcant fraction of total CI, and it is revealed in measurements of
maximal respiratory capacity (MRC). Indeed, we can rescue MRC
with blockade of iNOS during stimulation (Supplementary
Fig. 6E, F) and exposure to low dose of NO affects MRC but not
basal OCR53. Therefore, we propose that, during stimulation, low
NADH/NAD+ due to NO-mediated blunting of mentioned
enzymatic activities, promotes the accumulation of CI in D form
facilitating degradation and favoring full glycolytic commitment.
Regardless of the mechanism, oxidation of isocitrate (CI) is
maintained indicating that inhibition of aconitase occurs before
considerable inhibition of the ETC complexes, in line with pre-
vious work24. Although we do not know if the disappearance of
CII is linked to decline of CI and/or is the result of the same
mechanism, we suggest that suppression of OXPHOS during
acute NO exposure is due to substrate deprivation rather than via
direct effects on mitochondrial ETC. Further experimentation
will be required to test this hypothesis.
Given in vivo plasticity and demonstrations that ex vivo
manipulation alters cellular redox states and metabolomes54, the
fact that we found that macrophages activated in vivo share many
metabolic features with BMDMs in vitro has implications for our
understanding of the regulation of immunity and disease patho-
genesis. Our data represent one of few investigations of TCA
rewiring in vivo. It is worth noting, however, that in our model,
peritoneal macrophages did not accumulate citrate as has been
demonstrated extensively in vitro. Nevertheless during the modiﬁed
Schwartzman reaction, peritoneal macrophages changed citrate/
isocitrate ratios and exhibited reduced levels of ACO2 activity
demonstrating that the “break” in the TCA is a relevant char-
acteristic in vivo. Likely, differences in availability of carbon sources
and/or oxygen tension within tissue environments are the reason
why in-vivo settings only partially reﬂect in vitro data sets35,55.
We are the ﬁrst to demonstrate alterations in the metabolic
signature of the peritoneal lavage during stimulation, where we
documented NO-dependent regulation of citrate, α-KG, arginine
metabolism and itaconate production. Future studies should
determine how peritoneal citrate is controlled by NO and what
role that may play during the inﬂammatory response. Regardless,
our study highlights that, during inﬂammation, the macrophage
metabolically responds to the surrounding environment and at
the same time, directs alterations of it, presumably to facilitate
pathogen clearance. Together with our recent ﬁndings20, our new
data suggest that additional work is needed to understand the
ramiﬁcations of immune cell-mediated metabolic alteration of the
peritoneal niche on infection, inﬂammation and cancer in order
to therapeutically manipulate the metabolites within.
The data presented here provide novel interpretation of the
biochemical basis of macrophage metabolic programming. This
process is orchestrated by NO and is a result and not a direct
mediator of polarization. Given the known differences in NO
ﬂuxes generated by human and murine macrophages, our data
change our understanding of metabolic rewiring and raises the
possibility that substantial sources of non-myeloid NO in
humans56 may have metabolic effects by acting in cis or trans on
immune cells within the tumor microenvironment.
Methods
Mice. Nos2−/− (B6.129P2-Nos2tm1Lau/J purchased from the Jackson Laboratory)
and C57BL/6 control mice were bred and propagated in the same room in the
Frederick National Laboratory Core Breeding Facility. Animal care was provided in
accordance with the procedures in “A Guide for the Care and Use of Laboratory
Animals”. Ethical approval for the animal experiments detailed in this manuscript
was received from the Institutional Animal Care and Use Committee (Permit
Number: 000386) at the NCI-Frederick. All mice used were used between 6 and
10 weeks old and were age- and sex-matched for each experiment.
Macrophage culture and stimulation. Total cells from the bone marrow were
plated at 7.0 × 105/mL for 5–7 days in complete Dulbecco’s modiﬁed Eagles media
(DMEM) (Gibco #11965) supplemented with 2 mM Glutamine, 10% FBS, 100 U/
mL Penicillin/Streptomycin and 20 ng/mL mouse macrophage colony-stimulating
factor (M-CSF) allowing for proper BMDM differentiation and growth3. After
growing BMDM for 6 days in culture, cells were placed in complete culture media
and treated with vehicle (PBS) or 100 ng/mL of LPS or the combination of LPS
(100 ng/mL) and 50 ng/mL of IFNγ for 8–24 h. “Activation”, “stimulation”, and
“polarization” in the manuscript are referred to LPS+ IFNγ treatment, unless
speciﬁed. Where indicated, cells where pretreated with aminoguanidine (AG;
1 mM, Sigma Aldrich), dimethyl α-KG (D-αkG; 1 mM, Sigma Aldrich), dimethy-
loxalylglycine (DMOG; 100 μM, Sigma Aldrich), FeSO4 (50 μM, Sigma Aldrich)/
sodium (Na) thiosulfate (3 mM, Sigma Aldrich), Fluoroacetate (FA; 10–20 mM,
Sigma Aldrich) for 1 h as indicated prior to addition of LPS+ IFNγ for 8–24 h.
Resting cells and LPS/IFNγ-treated Nos2−/− BMDM were additionally treated with
DETA/NO (100 up to 500 μM) where indicated.
RNA/DNA isolation and quantitative PCR. Cells (2 × 106) in wells of 6-well
plates were washed and total RNA was extracted using the High-Pure RNA iso-
lation kit (Roche, 11828665001), as per manufacturer’s instructions (with the
addition that 2-mercaptoethanol (1% v/v) was added to the lysis buffer). cDNA was
synthesized from 1 μg RNA using the High-Capacity cDNA Reverse Transcription
kit (Applied Biosystems, 4387406) and quantitative RT-PCR was performed with
an Applied Biosystems 7300 using Eagle Taq (Roche) reagent and ABI Taqman
gene expression probes and normalization was performed against Hprt
(Mm01545399_m1). Values are expressed as relative expression using the ΔΔCt
method. Data were normalized to WT control.
For measurements of mitochondrial DNA, DNA was extracted with AllPrep
DNA/RNA Kit (Qiagen, #80284) and quantitative PCR was carried out with
mitochondrial 16 s DNA probe (Mm04260181_s1) and normalized versus β-actin
DNA (Mm00607939_s1).
Immunoblotting. Protein expression in stimulated macrophages was determined
by western blot using 20 μg of total protein per sample3. Separation into cyto-
plasmic and nuclear fractions was performed using 0.4 M NaCl and 0.1% Nonidet
P-40 (NP-40) in extraction buffer57. SDS immunoblots (IBs) were performed to
evaluate steady-state protein levels of structural subunits of mitochondrial com-
plexes assessed by native gels. Antibodies in this study are as follows: anti ACO1/2,
anti IDH1, anti SDHB, anti SDHA, anti NDUFS1, anti MTCO1, anti ATP5A, anti
NDUFS8, anti total OXPHOS (Complex V, ATP5A subunit; Complex IV, COXII
subunit; Complex III, UQCRC2 subunit; Complex II, SDHB; Complex I,
NDUFB9 subunit) and anti Phospho-S293 PDHE1-alpha were from Abcam; anti-
FECH antibody was from Proteintech; anti phospho-, total PDK1 and anti HIF1α
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were from Novus Biologicals. For loading control anti CS, anti TOM20, Lamin B
and anti β-actin were used (respectively from Sigma, Santa Cruz, Abcam, and
Millipore).
Spectrophotometric measurement of aconitase, IDH, and PDH. Aconitase
enzymatic activity was assayed by the disappearance of cis-aconitate at 240 nm
measured with a 96-well spectrophotometer plate reader (VersaMax, Molecular
Devices): 2 × 106 stimulated BMDM were lysed with 0.2% Triton X-100 in 0.15 M
NaCl buffered with 30 mM Tris-HCI, pH 7.2. Lysate was centrifuged (5,000 g for
15 min) and 100 μg of supernatant was immediately assayed for aconitase activity
at 25 °C in the presence of 0.02% BSA. The reaction was started with the addition
of 0.2 mM cis-aconitate and enzyme activity was determined from the initial
reaction rate. An extinction coefﬁcient of 3.41/cm/ mM was used for cis-aconitate.
For mitochondrial aconitase enzymatic activity measurements, 20 × 106 cells were
permeabilized beforehand with 0.007% digitonin to remove cytoplasmic proteins30.
Isocitrate dehydrogenase was measured spectrophotometrically in both whole-
cell and permeabilized-cell lysates by following the reduction of NADP+ or
NAD+with isocitrate as substrate. Isocitrate (1 mM ﬁnal concentration) was
added to the lysates to start the reaction and the coupled reduction of NADP+
(NAD+) (0.1 mM) was followed at 340 nm. Reaction was performed at 37 °C in a
buffer containing 30 mM Tris-HCl, 0.15 M NaCl, and 10 mM MgCI2, pH 7.258.
Formation of NADH was used to measure pyruvate dehydrogenase complex
activity59. The reaction mixture here contained 2.5 mM NAD, 0.1 mM Coenzyme
A, 5 mM pyruvate, and 1 mM MgCl2. A base-line was determined with sample and
reference both containing the entire reaction mixture except for pyruvate.
Spectrophotometric readings were measured every 20 s for 30 min.
Metabolic analyses. OCR and ECAR were examined using the XF96 Seahorse
Metabolic Analyzer from Seahorse Biosciences (North Billerica, MA). Brieﬂy,
BMDM at day 7 of differentiation were plated at a seeding density of 0.8 × 105 cells/
well in 200 μL of complete media in an extracellular ﬂux tissue culture plate35.
BMDM were incubated and stimulated with or without 100 ng/mL of LPS and
50 ng/mL of IFNγ for the times and presence of inhibitors indicated in the ﬁgures.
Prior to metabolic test the media was removed and replaced with Seahorse XF
assay media (#102365-100) containing 25 mM glucose, 2 mM glutamine, and
20 ng/mL M-CSF and the plates containing cells were incubated for 30 min at 37 °C
with no CO2. Port additions and times were used as indicated in the ﬁgures.
For mitochondrial stress test (extracellular ﬂux analysis), 1.26 μM oligomycin
was injected in port A, 0.67 μM FCCP ﬂuoro-carbonyl cyanide phenylhydrazone in
port B, and 0.2 μM rotenone/1 μM antimycin A in port C. For experiments of
longer OCR monitoring in BMDMs throughout addition of stimulants, the LPS+
IFNγ mixture was injected in port A and after 9 h, dichloroacetate (DCA; 10 mM,
Sigma Aldrich) or FA (10 mM) were injected in port B. For glutamine deprivation
studies, prior to metabolic test the media was replaced with complete Seahorse XF
media without glutamine.
For respiration measurements, OCR was examined using the XF96 Seahorse
Metabolic Analyzer60. Brieﬂy, BMDM at day 7 of differentiation were plated at a
seeding density of 0.8 × 105 cells/well in 200 μL of complete media and activated O.
N. Upon XF96 run, media was replaced with MAS buffer (220 mM Mannitol,
70 mM sucrose, 10 mM KH2PO4, 5 mM MgCl2, 2 mM HEPES, 1 mM EGTA, 0.2%
fatty acid free BSA). Oxygen consumption was monitored permeabilizing cells with
1 nM PMP (Seahorse Biosciences). State III respiration, deﬁned as ADP-stimulated
respiration in intact, unpoisoned mitochondria, in the presence of excess substrate
was assessed61. Citrate (5 mM), ADP (4 mM) and the mentioned permeabilizer
were co-injected in port A. Isocitrate (5 mM) was injected in port B; 5 mM
tartronate (2-hydroxy malonate) was also added to the respiration medium as an
exchange partner for the tricarboxylate-transporter, which facilitates the entry of
citrate and isocitrate into the mitochondrial matrix21,30. Rotenone 0.2 μM was
injected in port C.
Pyruvate-elicited respiration was assessed in permeabilized cells offered 5 mM
pyruvate, 2.5 mM malate (port A), and 0.2 μM rotenone (port B)60. For complex II-
mediated respiratory activity 10 mM succinate, in the presence of 0.2 μM rotenone,
was added upon permeabilization. 1 μM antimycin A was injected in port B. The
concentration of the above mentioned substrates are ﬁnal concentrations.
Glucose uptake was assayed in cultured BMDM using a hand-held glucometer
(Accu-Check, Roche, Diagnostics, IN) or measuring its levels with GC-MS where a
control sample of complete DMEM incubated at the same experimental conditions
without cells was provided.
Metabolomics and 13C tracing studies. WT and Nos2−/− BMDM (~107 cells per
sample) were treated with vehicle (PBS) or 100 ng/mL of LPS for 24 hours. Cells
were then washed, gently scraped, pelleted, snap frozen in liquid nitrogen and sent
to West Coast Metabolomic Center at the University of California, Davis (Davis,
CA) for metabolomic analyses. Same pipeline was applied for WT and Hif1α−/−
BMDM treated O.N. with vehicle (PBS) or LPS+ IFNγ for untargeted studies.
Targeted measurements were performed through electrospray ionisation mass
spectrometry (ESI-LC–MS/MS) analysis in multiple reaction monitoring mode
with an Agilent 6410B Triple Quadrupole mass spectrometer interfaced with a
1200 Series HPLC quaternary pump (Agilent) available in house at NCI-Frederick.
Cell pellets were washed and resuspended in 80% methanol and 50 μL or 4x
concentrated mouse peritoneal lavage were mixed with 450 μL of 100% methanol.
Phase separation was achieved by centrifugation at 4 °C and the methanol-water
phase containing polar metabolites was separated and dried using a vacuum
concentrator. The dried metabolite samples were stored at −80 °C and resuspended
in milli-Q water the day of analysis.
Four concentrations of standards, processed under the same conditions as the
samples, were used to establish calibration curves62. The best ﬁt was determined
using regression analysis of the peak analyte area. Chromatographic resolution was
obtained in reverse phase on a Zorbax SB-C18 (1.8 μm; Agilent) for aminoacids
and a Eclipse Plus C18 (1.8 μm; Agilent) for TCA intermediates, with a ﬂow rate set
at 0.4 mL/min.
For 13C-carbon incorporation from [U-13C] glucose or glutamine in
metabolites, after O.N. exposure to LPS/IFNγ (day 7 of differentiation), cells were
washed with PBS and DMEM containing dialyzed FBS and labeled substrate, i.e.,
[U-13C] glucose or [U-13C] glutamine (Cambridge Isotope Laboratories) was
added for 4 h (conﬁrmation of steady-state). For mass spectrometry analysis, cells
were scraped in 80% methanol and phase separation was achieved by
centrifugation at 4 °C and the methanol-water phase containing polar metabolites
was separated and dried using a vacuum concentrator. The dried metabolite
samples were stored at −80 °C. Isotopologue distributions and metabolite levels
were measured with a 7890A GC system (Agilent Technologies) combined with a
Quattro Premier MS system (Waters)63. m+ 0 to m+ n indicate the different mass
isotopologues for a given metabolite with n carbons, where mass increases due to
13C-labeling64.
For NMR analysis, labeled cells were rinsed in cold PBS, quenched in cold
acetonitrile, extracted for metabolites, and prepared in a solution of 1xDSS-PO4
50% D2O. NMR spectra were recorded at 14.1 T under standard acquisition
conditions using 1D proton and 1D [1H]{[13C]}-heteronuclear single-quantum
coherence (HSQC) for isotopomer analysis. The HSQC analysis compared the peak
intensity of protons attached to [13C] atoms (akin to [13C] abundance) at speciﬁc
positions of various metabolites. Peaks were assigned and quantiﬁed65. The 1-D
HSQC spectra were normalized to protein content and spectral parameters so that
intensity or metabolite resonances reﬂected their protein amount.
Isolation of mitochondria and immunoprecipitation. Brieﬂy, mitochondria from
BMDM pellets (~107 cells) were isolated from the cytosolic fractions after cell
permeabilization with a buffer containing 0.1% digitonin in 210 mM mannitol,
20 mM sucrose, and 4 mM HEPES. The pellets after centrifugation at 700 x g for
5 min contained mitochondria, which were isolated by differential centrifugation
and solubilized in lysis buffer I containing 50 mM Bis-Tris, 50 mM NaCl, 10% w/v
Glycerol, 0.001% Ponceau S, 1% Lauryl maltoside, pH 7.2, protease and phos-
phatase inhibitors66.
Isolated mitochondria were lysed in a buffer containing 25 mM Tris, 200 mM
NaCl, 1 mM EDTA, 1% NP-40, 5% glycerol (pH 7.4) to obtain a ﬁnal protein
concentration of 1 μg/μL. Five-hundred micrograms of total mitochondrial
proteins were used for the IP with the co-IP kit from Pierce (#26149). Beads with
covalently bound antibody (2 μg) (anti-IgGs was used as a negative control) were
incubated with mitochondrial lysate ON at 4 °C. After, beads were washed ﬁve
times with lysis buffer, and the bound complexes were ﬁnally eluted with Tris/Gly
pH 2.8 (50 μL/ IP sample) at room temperature for 10 min.
Native PAGE (BN-PAGE) and native immunoblots. The Native PAGE Novex
Bis-Tris gel system (Thermo Fisher Scientiﬁc) was used for the analysis of native
membrane protein complexes and native mitochondrial matrix complexes; 20 μg of
membrane protein extracts were loaded/well; the electrophoresis was performed at
150 V for 1 h and 250 V for 3.5 h66. For the native IBs, polyvinylidene ﬂuoride was
used as the blotting membrane. The transfer was performed at 25 V for 4 h at 4 oC.
After transfer, the membrane was washed with 8% acetic acid for 20 min to ﬁx the
proteins, and then rinsed with water before air-drying. The dried membrane was
washed 5- 6 times with methanol (to remove residual Coomassie Blue G-250),
rinsed with water and then blocked for 2 h at room temperature in 5% milk, before
incubating with the desired antibodies diluted in 2.5% milk O.N. at 4 oC. In order
to avoid strip and reprobing of the same membrane, which might allow detection
of signals from the previous IBs, samples were loaded and run in replicates on
adjacent wells of the same gel, and probed independently with different antibodies.
Complex I, complex II, and complex IV in-gel activities. For complex I activity,
after resolution of the respiratory chain complexes by BN-PAGE, the gel was
incubated with 0.1 M TrisCl, pH 7.4, containing 1 mg/mL nitrobluetetrazolium
chloride (NBT) and 0.14 mM NADH at room temperature for 30–60 min. For
complex II, detection of succinate CoQ-reductase activity (SQR) (CoQ-mediated
NBT reduction) was performed by incubating the gel for 30 min with 84 mM
succinate, 2 mg/mL NBT, 4.5 mM EDTA, 10 mM KCN, 1 mM sodium azide and
10 μM ubiquinone in 50 mM PBS, pH 7.4. For complex IV, the gel was incubated in
50 mM phosphate buffer pH 7.4 containing 1 mg/mL DAB (3,3’-diaminobenzi-
dine) and 1 mg/mL cytochrome c at room temperature for 30-45 min66.
ARTICLE NATURE COMMUNICATIONS | https://doi.org/10.1038/s41467-020-14433-7
14 NATURE COMMUNICATIONS |          (2020) 11:698 | https://doi.org/10.1038/s41467-020-14433-7 | www.nature.com/naturecommunications
PDHE3 in-gel activity. 30 μg of mitochondrial matrix lysates were run on
Blue Native PAGE at 150 V for 1 h, followed by 1 h at 250 V on ice. The gel was
soaked into 50 mM potassium phosphate buffer (pH 7.0) assay buffer, containing
0.2 mg/mL NBT and 0.1 mg/mL NADH for 30–45 min until DLD activity
developed47.
Microarray. WT and Nos2−/− BMDM (1 × 106 cells/mL in 10 cm Petri dishes)
were treated with vehicle (PBS) or 100 ng/mL of LPS and 50 ng/mL of IFNγ for 8 h.
Cells were then washed and total RNA was extracted using the High-Pure RNA
isolation kit (Roche, 11828665001), as per manufacturer’s instructions (with the
addition that 2-mercaptoethanol (1% v/v) was added to the lysis buffer). One
microgram of RNA from each sample was then sent to CCR—Genomics, Micro-
array Core Service, LMT Gene Expression Group at the Frederick National
Laboratory for Cancer Research, Frederick (Frederick, MD) for Affymetrix Mouse
Genome 430 2.0 Array.
For differential expression analysis, we input CEL ﬁles into Partek Genomic
Suite software (Partek Inc.) and sample treatment information was manually
annotated. Data were processed by the build-in gene expression pipeline, which
included the RMA algorithm for data normalization and converted to log2 values.
Data were deposited in GEO NCBI under the accession GSE115120. Differentially
expressed genes were identiﬁed by analysis of variance (ANOVA). The threshold
value has been set at 1.5-fold change and a false discovery rate (FDR) < 0.5.
Differential expressed genes were analyzed by ingenuity pathway analysis (IPA;
Ingenuity Systems).
Cytokine production. For cytokine analysis BMDM at day 7 of differentiation were
plated at a seeding density of 1 × 105 cells/well in 200 μL of complete media in wells
of 96-well plates. Plates were incubated and stimulated with or without 100 ng/mL
of LPS and 50 ng/mL of IFNγ in the absence or presence of inhibitors (where
indicated in the ﬁgures). The plates were incubated for 24 h before supernatant
removal. The cytometric bead array kits (BD Biosciences) were used to quantify
IL10, IL1β, Mip1α and KC in 50 μL supernatant, while a 1:5 dilution was used for
detection of IL6, IL12p40, TNFα, and MCP1 cytokines. Kits were used as per
manufacturer’s instructions.
Shwartzman reaction model of sepsis in mice. Macrophages were recruited into
the peritoneum by an i.p. injection of 0.5mL of 4% Brewer’s thioglycollate broth
(Difco, Detroit, MI)67,68. Mice were placed on a heating pad and monitored daily.
Seventy-two hours later sepsis was induced by the Shwartzman reaction with
the priming injection of 15 μg IFNγ i.p. followed 12 h later by a challenge LPS
injection39,69. The optimal dose of LPS ranged between 30 and 100 μg (1.25–4mg/kg).
Cells were obtained lavaging mouse peritoneum 12 h post challenge with 4mL PBS
using a 21-G needle.
Cell puriﬁcation from peritoneal lavage ﬂuid was performed by magnetic
puriﬁcation. Neutrophil depletion was achieved incubating total cells with α-Ly-
6G-Biotin in the presence of PBS with 5 mM ethylenediaminetetraacetic acid
(EDTA), 0.5% BSA for 15 min at 4 °C and sorting with streptavidin microbeads
and LS columns as per manufacture’s instructions (Miltenyi Biotec). Macrophage
were isolated from ﬂow throughs, carried out with addition of CD11b microbeads
with incubation for 20 min at 4 °C followed by positive selection with magnetic
columns (Miltenyi Biotec).
Cell pellets were washed with NaCl 154 mM and subjected to metabolite
extraction for targeted metabolomics studies, together with concentrated
lavage ﬂuid.
NO detection. Nitrite, the oxidation product of NO, was measured using the
Griess reaction according to the manufacturer’s instructions (Invitrogen™,
#G7921).
Statistical analysis. Data are presented as means ± standard error of mean
(± SEM) and are representative of at least two independent experiments. Statistical
analysis was performed using GraphPad Prism 7. One-way or two-way ANOVAs
followed post tests and linear regression were used when multiple groups were
analyzed as are indicated in ﬁgure legends. Student’s t-test was used for statistical
analysis when two groups were analyzed. All data are assumed normally distributed
and were log transformed where appropriate before analysis. Statistical signiﬁcance
was set at *p < 0.05.
Reporting summary. Further information on research design is available in
the Nature Research Reporting Summary linked to this article.
Data availability
All data supporting the ﬁndings of this study are available with the article, and can also
be obtained from the corresponding author. Microarray data has been deposited in the
NCBI GEO repository with an accession ID GSE115120. Metabolomics data is available
at the NIH Common Fund’s National Metabolomics Data Repository (NMDR) website,
the Metabolomics Workbench, where it has been assigned Project ID PR000867. The
data can be accessed directly via it’s Project https://doi.org/10.21228/M8MM6Z. The
source data underlying Figs. 1–5 and 7 and Supplementary Figs. 1–7 are provided as a
Source Data ﬁle.
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